Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam induction with high-flow nasal oxygen vs face mask ventilation in cardiovascular surgery
jRCT1032260135Not yet recruiting
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of remimazolam in cardiac morbidity (2 arms). Primary endpoint: Incidence of hypotension. Planned start May 2026; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
cardiac morbidity
Beyond the preview
Go deeper on jRCT1032260135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1032260135.